Login / Signup

Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia in the United Kingdom: A Discrete Choice Experiment.

David John MottJake HitchSamantha NierZack Pemberton-WhiteleyChristopher Skedgel
Published in: Patient preference and adherence (2024)
Our results indicate that patients are strongly concerned about the chance of response, as well as quality of life (to a lesser extent), when faced with different treatment options in the relapsed/refractory setting. However, there is significant preference heterogeneity within the patient population, and other treatment characteristics also matter to many.
Keyphrases
  • acute lymphoblastic leukemia
  • case report
  • diffuse large b cell lymphoma
  • newly diagnosed
  • ejection fraction
  • multiple myeloma
  • hodgkin lymphoma
  • decision making
  • patient reported